As expected, the presence of FLT3 ligand did not appear to significantly affect cell proliferation for null FLT3‐ or wt FLT3‐expressing AML lines treated with midostaurin, and the high or low expression of FLT3 in the different cell lines did not seem to affect their sensitivity to midostaurin in the presence of FLT3 ligand (Figure [Link], [Link], [Link], [Link]). The gene discussed is FLT3; the disease is acute myeloid leukemia.